Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis-Reference-Cited by-同舟云学术

Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis

Published:2022-02 Issue: Volume:240 Page:205-213
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Correll Christoph U.^ORCID,Tocco Michael,Pikalov Andrei,Hsu Jay,Goldman Robert

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference55 articles.

1. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am J Psychiatry,2005

2. A rating scale for drug-induced akathisia;Barnes;Br J Psychiatry,1989

3. Clinical predictors of therapeutic response to antipsychotics in schizophrenia;Carbon;Dialogues Clin Neurosci,2014

4. Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study;Citrome;Int Clin Psychopharmacol,2012

5. Safety and tolerability of antipsychotic treatment in young patients with schizophrenia;Correll;J Clin Psychiatry,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review;Expert Opinion on Drug Safety;2024-09-03

2. Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy;Drug Design, Development and Therapy;2023-09

3. Narrative review of the advances in the pharmacotherapeutic management of juvenile-onset schizophrenia;Expert Opinion on Pharmacotherapy;2023-05-01

4. Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice;Expert Opinion on Pharmacotherapy;2022-11-02